Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs systemic glucocorticoids for grade 2 immune-related pneumonitis
ChiCTR2000037658Phase 4Recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of budesonide and methylprednisolone in immune-mediated pneumonitis and bronchial carcinoma (2 arms), sponsored by Shanghai Pulmonary Hospital. Primary endpoints: Treatment response rate and Immunotherapy suspended time. Started Oct 2020; status: recruiting.
02
Drugs
budesonidemethylprednisolone
03
Conditions
immune-mediated pneumonitisbronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2000037658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037658.